$Viveve Medical (VIVE.US)$ - SEP 23, fundamentally, Viveve ...
$Viveve Medical (VIVE.US)$ - SEP 23,
fundamentally,
Viveve Announces Issuance of New Method Patent for Stress Urinary Incontinence in Australia
Viveve Announces Issuance of New Method Patent for Stress Urinary Incontinence in Australia
technically,
has a target at 2.45
SL = 2.35
has a target at 2.45
SL = 2.35
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Tartooth : Is this goal a bit underestimated?